Home / SUNPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does SUNPHARMA.NS make money? Does SUNPHARMA.NS have pricing power? What's the Earnings Whisper? Will SUNPHARMA.NS profit more as the business scales? What is SUNPHARMA.NS's management track record? Is SUNPHARMA.NS's current price justified?

Sun Pharmaceutical Industries Limited

₹1758.8 +$37.70 (+2.19%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹1764

Day Range

₹1743.5₹1764.9

Year Range

₹1583.7₹2046.9

Market Cap

4.22T

AVG Volume

1.9M

Trailing/Forward PE

34.89/27.21

PEG ratio

4.61

Dividend Yield

0.91%

Next Earnings Date

2026-10-30

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

SUNPHARMA.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	599.11B
26 Q4	584.62B
26 Q3	568.09B
26 Q2	549.64B
26 Q1	537.77B
25 Q4	525.78B
25 Q3	516.02B
25 Q2	503.08B
25 Q1	492.09B
24 Q4	484.97B

Net Income (INR) · TTM

SUNPHARMA.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	120.96B
26 Q4	114.79B
26 Q3	109.15B
26 Q2	104.5B
26 Q1	103.72B
25 Q4	109.29B
25 Q3	114.34B
25 Q2	110.54B
25 Q1	103.89B
24 Q4	95.76B

Operating Income (INR) · TTM

SUNPHARMA.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	137.38B
26 Q4	135.53B
26 Q3	169.55B
26 Q2	204.51B
26 Q1	244.41B
25 Q4	278.15B
25 Q3	272.19B
25 Q2	261.3B
25 Q1	250.59B
24 Q4	244.24B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Sun Pharmaceutical Industries Limited

Video analysis: SUNPHARMA.NS

News: SUNPHARMA.NS

Similar companies